Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cohort Study of Pancreatic Cancer Risk
Sponsor: Mayo Clinic
Summary
This study is designed to develop a cohort of individuals without pancreatic cancer, but who are at increased risk of developing it due to family history or genetic predisposition. These high-risk individuals will be asked to provide baseline and annual (serial) follow-up blood samples for the duration of the study funding. \[Blood collection was discontinued August 2025.\] Mayo Clinic is part of a national Pancreatic Cancer Detection Consortium (PCDC) which aims to establish a high-risk cohort with the goal of validating blood biomarkers (discovered/developed outside of this protocol) using the samples collected serially (annually) that predict or detect pancreatic cancer prior to clinical diagnosis.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
419
Start Date
2019-12-11
Completion Date
2027-12-31
Last Updated
2026-02-19
Healthy Volunteers
Yes
Conditions
Locations (1)
Mayo Clinic
Rochester, Minnesota, United States